Cancerfighter’s Weblog

Alternative cancer therapies and ideas

Can maths cure cancer?

Posted by Jonathan Chamberlain on June 20, 2008


Spanish scientists use maths to cure terminal liver cancer

By using a mathematical formula formula designed to strengthen the immune system, a team of scientists in Spain have succeeded in curing a patient who was in the last stage of terminal liver cancer.

The team of researchers from the Complutense University in Madrid believe that this discovery could open new doors for the treatment of solid cancerous tumours.

The new treatment was developed in 1998 by a team led by Antonio Bru, a physicist who bases his theory on the idea that the evolution of solid tumors depends on a mathematical equation which defines their biological growth. An equation is then obtained in the laboratory and used to design a therapy to destroy the tumor.

The scientists, who have carried out successful tests on mice over the past few years, announced yesterday that the only human experiment they have carried out so far has been a complete success.

Apparantly the patient was suffering from liver cancer which had been diagnosed by his doctors as terminal and in its final stage. The scientists used a mathematical formula to create a treatment based on neutrofiles that strengthened the patient’s immune system. The patient responded well to the treatment immediately and has since made a total recovery and has returned to work.

The treatment produces no side effects.The Spanish scientists believe that their theory could be applied to treat all kinds of solid tumors although they will need to carry out many more tests on human patients before they can be sure.

Update 1/06/2005:

Today, the Complutense University (whose switchboards have apparantly been innundated with phone calls from people wanting to find out more about this news item) has published a communication on its website with a brief communication from Prof. Antonio Bru. The full article is here. Below is a translation of Professor Bru’s brief note which appears at the end of the article:

Given the expectation generated by the news of the publication of the article Regulation of neutrophilia by granulocyte colony-stimulating factor: a new cancer therapy that reversed a case of terminal hepatocarcinoma in the Journal of Clinical Research, I would like to make the following points:

1) The proposed treatment is still at an experimental stage and needs much wider experimentation before it can be validated.

2) For this reason, at this moment there is no treatment protocol which enables it to be applied as a general treatment.

3) Given that it is impossible for the Complutense University of Madrid to answer all the phone calls received, and bearing in mind how they can disrupt normal teaching and research activity, please send any enquiries to the following email address: bru@mat.ucm.es
Dr. Antonio Brú, Departamento de Matemática Aplicada
Facultad de Ciencias Matemáticas, Universidad Complutense de Madrid

Related:
The Universal Dynamics of Tumor Growth by Antonio Bru and his team of researchers.

3 Responses to “Can maths cure cancer?”

  1. […] admin wrote an interesting post today onHere’s a quick excerpt […]

  2. Manel said

    http://www.mat.ucm.es/~abruespi/

    Pinning of tumoral growth by enhancement
    of the immune response
    http://www.ncbi.nlm.nih.gov/pubmed/15245
    196?ordinalpos=7&itool=EntrezSystem2.PEntrez.Pubme
    d.Pubmed_ResultsPanel.Pubmed_RVDocSum

    Comments on the Article “The Universal Dynamics of Tumor Growth” By A.
    Br Et Al.
    http://www.redorbit.com/news/science/149281/c
    omments_on_the_article_the_universal_dynamics_of_t umor_growth/

    Reply to
    Comments by Buceta and Galeano Regarding the Article “The Universal Dynamics of
    Tumor Growth”
    http://www.pubmedcentral.nih.gov/articler
    ender.fcgi?artid=1305521

    Instituto Americano de
    Fisica;
    http://www.aip.org/pnu/2004/686.html

    http://156.35.33.135/mediateca/jsp/fi
    cha.jsp?video=mms://video.innova.uniovi.es/webConf
    erencias/2006/240306_AntonioBru.wmv&posicion=-1

  3. Manel said

    http://www.news-medical.net/?id=34242

    Genetic evolution of tumours according to their growth dynamics.

    Published: Friday, 11-Jan-2008

    Medical Studies/Trials
    A study co-directed by the Universidad Complutense de Madrid and La Paz hospital in Madrid identifies a protein of high expression in cells located at the tumour boundary that could play an essential role in the evolution of tumours and their invasive potential.
    It is well accepted that tumour growth is a very complex process with many intervening factors, and in spite of being the subject of most investigations on a global scale; there are still many aspects that remain unknown, one of the most interesting of which is the relation between the dynamics of solid tumour growth and their gene expression.
    The universal dynamics of tumour growth (Br?Albertos S, Luis Subiza J, Garc?Asenjo JL, Br?Biophys J. 2003) established that the growth dynamics of all tumours is similar. Such growth dynamics implied that the growth rate of the tumour follows a lineal function and that most of its activity takes place at the outer tumour boundary. This establishes a huge difference in the number of cell divisions that a cell located at the tumour boundary undergoes from the original tumour cell, when compared to the traditional model based on the Gompertzian growth pattern. Considering a tumour 2 cm3 in volume, following the previous model, a cell at the boundary of the tumour will divide 32 times from the original tumour seed, and using the new growth dynamics for solid tumour, the number of boundary cell divisions is estimated at 800 times from the original tumour seed.
    Bearing in mind that there is a correlation between the genetic evolution (accumulation of anomalies and aberrations) and the number of cell divisions of a cell, and that the cells at the tumour boundary are always the ones with the largest number of divisions, there must exist a difference in the genetic expression inside the solid tumour depending on the distance from the tumour seed. Based on this hypothesis, the research groups managed by Dr. Antonio Br?m the department of applied mathematics at the Universidad Complutense de Madrid and Dr. L?-Collazo from the research and investigation department at the La Paz hospital in Madrid, started working on the study of the genetic expression profiles of sample cells from the C6 cell line of brain tumours inoculated in rats. Several researchers from different Spanish research institutions participated in the study; the genetic expression of samples at the centre, the outer tumour boundary and the healthy adjacent tissue were analysed.
    The results of the investigation are now published in the December edition of the specialised magazine Medical Oncology (Position-dependent expression of GADD45alpha in rat brain tumours. Br?Del Fresno C, Soares-Schanoski A, Albertos S, Br?Porres A, Rollán-Landeras E, Dopazo A, Casero D, G?-Pi?, Garc?L, Arnalich F, Alvarez R, Rodr?ez-Rojas A, Fuentes-Prior P, L?-Collazo E. Med Oncol. 2007;24 (4):436-44). Among the conclusions reached, the most relevant comes from the difference in the nuclear protein GADD45a, which regulates the cellular response to DNA damage and stress signals. This protein is expressed in many normal tissues, particularly in cells in a quiescent state (G0 phase of the cell cycle). The concentration of GADD45a increases during G1 phase of the cell cycle and greatly decreases when the cell is at S phase, demonstrating its crucial role in the response function to many stress or genotoxic signals. This protein has also been related to the programmed cell-death, the survival of cells and their innate immunity. In particular, it has been demonstrated that it inhibits cyclin B/CDC2, which constitutes a protein complex that controls the transition G2/M in the cellular cycle.
    According to the conclusions, this protein is expressed in much higher levels at the boundary than at the inside of solid tumours. This gives GADD45a a more important role in the evolution of the tumour and its invasive capability. The control of this cellular apoptosis regulator at the tumour expansion boundary is predicted by the universal dynamics of tumour growth elaborated by Dr. Br? his team over the last few years. These results allow for a better understanding of the genetic and phenotypic evolution that are currently explained in different theories of evolution as well as relating it to the growth dynamics of the tumour

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

 
%d bloggers like this: